Scinai Immunotherapeutics (SCNI) Liabilities and Shareholders Equity (2024 - 2025)
Scinai Immunotherapeutics (SCNI) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $11.6 million as the latest value for Q4 2025.
Scinai Immunotherapeutics (SCNI) has disclosed Liabilities and Shareholders Equity for 2 consecutive years, with $11.6 million as the latest value for Q4 2025.